Ptc Therapeutics (PTCT) Net Income Growth (1y) (2013 - 2026)
Ptc Therapeutics (PTCT) Net Income Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 6.48% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -6.81% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 46.75% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 151.28% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -99.90% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -12.04% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 327.74% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 95.87% |
| 10 | Ptc Therapeutics | 5.97 Bn | 3.75 Bn | 340.60 Mn | 228.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 228.75% |
| Mar 31, 2026 | -100.32% |
| Dec 31, 2025 | -124.77% |
| Sep 30, 2025 | 114.90% |
| Jun 30, 2025 | 34.61% |
| Mar 31, 2025 | 1,046.28% |
| Dec 31, 2024 | 276.59% |
| Sep 30, 2024 | 19.79% |
| Jun 30, 2024 | 50.13% |
| Mar 31, 2024 | 34.10% |
| Dec 31, 2023 | -38.36% |
| Sep 30, 2023 | -21.64% |
| Jun 30, 2023 | -30.77% |
| Mar 31, 2023 | -9.65% |
| Dec 31, 2022 | -49.03% |
| Sep 30, 2022 | 18.19% |
| Jun 30, 2022 | -28.48% |
| Mar 31, 2022 | 1.49% |
| Dec 31, 2021 | -134.00% |
| Sep 30, 2021 | -91.74% |